Brian Weinstein
Stock Analyst at William Blair
(1.35)
# 2,750
Out of 4,433 analysts
10
Total ratings
42.86%
Success rate
9.88%
Average return
Main Sectors:
Top Industries:
7 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DMTK DermTech | Downgrades: Market Perform | n/a | $0.57 | - | 2 | Nov 4, 2022 | |
| TXG 10x Genomics | Downgrades: Market Perform | n/a | $26.39 | - | 2 | Jul 15, 2022 | |
| GKOS Glaukos | Upgrades: Outperform | n/a | $111.39 | - | 2 | Feb 3, 2022 | |
| SERA Sera Prognostics | Initiates: Outperform | n/a | $8.43 | - | 1 | Aug 9, 2021 | |
| BDSX Biodesix | Initiates: Outperform | n/a | $1.53 | - | 1 | Nov 23, 2020 | |
| AWH Aspira Women's Health | Initiates: Outperform | n/a | $2.78 | - | 1 | Oct 30, 2020 | |
| QDEL QuidelOrtho | Upgrades: Outperform | n/a | $44.96 | - | 1 | Jul 18, 2017 |
DermTech
Nov 4, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $0.57
Upside: -
10x Genomics
Jul 15, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $26.39
Upside: -
Glaukos
Feb 3, 2022
Upgrades: Outperform
Price Target: n/a
Current: $111.39
Upside: -
Sera Prognostics
Aug 9, 2021
Initiates: Outperform
Price Target: n/a
Current: $8.43
Upside: -
Biodesix
Nov 23, 2020
Initiates: Outperform
Price Target: n/a
Current: $1.53
Upside: -
Aspira Women's Health
Oct 30, 2020
Initiates: Outperform
Price Target: n/a
Current: $2.78
Upside: -
QuidelOrtho
Jul 18, 2017
Upgrades: Outperform
Price Target: n/a
Current: $44.96
Upside: -